Roswell Park Cancer Institute Center Support Grant

  • Priore, Roger (PI)
  • Buitrago, Sandra (PI)
  • Nowak, Norma Jean (PI)
  • Mazurchuk, Richard (PI)
  • Bernacki, Ralph (PI)
  • Murphy, Gerald (PI)
  • Hyland, Andrew (PI)
  • Pendyala, Lakshmi (PI)
  • Morrison, Carl (PI)
  • Hutson, Alan David (PI)
  • Gross, Kenneth (PI)
  • Wallace, Paul (PI)
  • Adjei, Alex A. (PI)
  • Rustum, Youcef (PI)
  • Soloway, Paul (PI)
  • Johnson, Candace (PI)
  • Trump, Donald (PI)
  • Ip, Margot (PI)
  • Brooks, John (PI)
  • Kazim, A. (PI)
  • Alderfer, James (PI)
  • Cheney, Richard (PI)
  • Stewart, Carlton (PI)
  • Martin, Thomas (PI)
  • Black, Jennifer (PI)
  • Kepner, James (PI)
  • Lee, Kelvin (PI)
  • Walker, Jeff (PI)
  • Betz, Lydia (PI)
  • Wright, John (PI)
  • Todaro, Barbara (PI)
  • Nowack, Norma (PI)
  • Karr, James (PI)
  • Cotter, Brian (PI)
  • Hohn, David (PI)
  • Nowack, Norma (PI)
  • Yasko, Joyce (PI)
  • Kazim, A. (PI)
  • Alderfer, James (PI)
  • Stewart, Carlton (PI)
  • Black, Jennifer (PI)
  • Hawthorn, Lesleyann (PI)
  • Wallace, Paul (PI)
  • Gross, Kenneth (PI)
  • Trump, Donald (PI)
  • Walker, Jeff (PI)
  • Lee, Kelvin (PI)
  • AMBROSONE, CHRISTINE (PI)

Project: Research project

Project Details

Description

[unreadable]
DESCRIPTION (provided by applicant): The Roswell Park Cancer Institute (RPCI) has been continuously recognized as a Comprehensive Cancer Center since the NCI designation of such centers in 1974 and is now requesting continued federal support for the next five years. A free-standing research, education and clinical cancer care Institute, RPCI occupies a 27 acre campus near downtown Buffalo and has expanded to nearly 1.6M gsf of clinical and research space, a 16% increase since the last review period. [unreadable]
[unreadable]
RPCI serves a population base of ~1.5M in Western New York where the RPCI tumor registry is recording more than 3,400 new cancer patients per year. RPCI has strong collaborations with the University of Buffalo and the Hauptman-Woodward Institute for Structural Biology, but is a fully independent entity with Dr. Donald Trump, CCSG PI and RPCI President/CEO, answering only to the RPCI Board of Directors. [unreadable]
[unreadable]
Since the last competitive renewal, the RPCI has grown significantly as demonstrated by: 1) the recruitment of over 100 new faculty clinicians and researchers of which 43 are new CCSG members; 2) a 74% increase in total NCI funding and a 44% increase in total peer-reviewed funding; 3) a 73% increase in accrual to investigator-initiated, interventional clinical trials and a 44% increase to accrual in all interventional trials; 4) the addition of 4 new shared resources with an institutional investment of over $2.0 M and (5) the opening of a new, 177,000 gsf, state-of-the-art research building housing Program member laboratories and Shared Resources. With the growth in faculty has also come the recruitment of three Senior Leaders. In addition, a director for the newly created RPCI Office of Cancer Health Disparities Research has also been recruited. As part of the scientific growth within RPCI, a new disease-specific Research Program, the Prostate Program, has been added in this renewal bringing RPCI to a total of six Scientific Programs that also include Cancer Prevention & Population Sciences, Cell Stress & Biophysical Therapies, Genetics, Molecular Targets & Experimental Therapeutics and Tumor Immunology & Immunotherapy. [unreadable]
[unreadable]
With strong leadership and institutional commitment, RPCI will continue to focus on recruiting talented investigators to further expand research efforts targeting areas in genetics, investigational imaging and cancer health disparities. [unreadable]
[unreadable]
StatusFinished
Effective start/end date6/1/784/30/19

ASJC

  • Medicine(all)